TransAlgae
Rehovot
About TransAlgae
TransAlgae is a biotech company incorporated in the USA, with a research center located at the Science Park of Rehovot, Israel. TransAlgae develops and cultivates a variety of enhanced algae possessing high value products for the growing animal health markets. TransAlgae’s unique, patent pending technology platform harnesses algae as cell factories for the production of customized or off-the-shelf bio-molecules. The platform enables the development of dried (company owned) algae, engineered to contain enzymes, active molecules, vaccines or other proteins to be orally delivered to target organisms. TransAlgae has successfully transformed algae with various functional proteins. The developments are significantly applicable for the aquaculture and poultry industries. These scientifically tested improvements allow us to meet the demands of diverse markets.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $2.5M
- Funding stage: Seed
- Last round: Angel (Apr 2021)
- Website: transalgae.com
- Phone: (972) 089-3661
Industries & Categories
Biotechnology, Clean Energy, Environmental Engineering
Social Profiles
Canonical: https://fsome.com/organization/transalgae-4415 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.